GFACX | USGLX | GFACX / USGLX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 29 years | - |
Gain YTD | 17.200 | 3.159 | 544% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 301B | 2.03B | 14,828% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 17.61 | 3.72 | 473% |
Returns for 3 years | -0.26 | -4.78 | 6% |
Returns for 5 years | 38.27 | 24.57 | 156% |
Returns for 10 years | 58.73 | 59.08 | 99% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETIHX | 33.68 | 0.48 | +1.45% |
Eventide Healthcare & Life Sciences I | |||
GSVUX | 16.73 | 0.19 | +1.15% |
Goldman Sachs Large Cap Value R6 | |||
MLPSX | 88.38 | 0.73 | +0.83% |
ProFunds Mid Cap Value Svc | |||
FCDIX | 37.57 | 0.22 | +0.59% |
Fidelity Advisor Stock Selector Sm Cp I | |||
JHJIX | 23.00 | -1.97 | -7.88% |
JHancock ESG Large Cap Core I |